Germany
Japan
United Kingdom
China
Antibodies
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
.jpg?d=110x100 "User supplied image")
USD 379.00
In Stock
USD 428.00
In Stock
USD 379.00
In Stock
USD 428.00
In Stock
USD 524.00
In Stock
Mouse Monoclonal anti-CACNA1C Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 440.00
2 Weeks
Mouse Monoclonal alpha Tubulin Antibody (DM1A) - Microtubule Marker
| Applications | IHC, WB |
| Reactivities | Bovine, Chicken, Guinea Pig, Human, Mouse, Porcine, Rat, Xenopus |
| Conjugation | Unconjugated |
Mouse Monoclonal iNOS Antibody (4E5)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
TA336918 is a replacement of AM06772PU-N.
Active filters
Reactivities
- Mouse
Applications
- IHC
Clonalities
- Monoclonal
Filter by
Target Symbol
- MAP2K1 (171)
- NME1 (132)
- OTC (115)
- ERBB2 (95)
- MAP2K3 (95)
- ABCB1 (85)
- ERCC1 (71)
- LGALS3 (71)
- VSNL1 (71)
- PCNA (70)
- PIK3C2A (70)
- CTNNB1 (68)
- TOP2A (66)
- SENP2 (60)
- APP (57)
- JUN (56)
- ABAT (55)
- NCAM1 (54)
- VBP1 (53)
- BBOX1 (51)
- BCL2 (51)
- LTA4H (51)
- NPR3 (50)
- PARVA (50)
- PFKP (50)
- PIK3CG (50)
- PPP5C (50)
- UBE2G2 (50)
- MCM2 (48)
- MEF2C (48)
- TYMS (48)
- AKT1 (47)
- POR (46)
- ACAT2 (45)
- AKR1A1 (45)
- GCH1 (45)
- LOX (45)
- LPIN1 (45)
- PTPRE (45)
- AGR2 (44)
- ALDH1L1 (44)
- BTK (44)
- DEF6 (43)
- KRT18 (43)
- PDSS2 (43)
- TLE1 (43)
- MTOR (42)
- SQSTM1 (42)
- F13A1 (41)
- L1CAM (41)
- ACAA2 (40)
- CRYAB (40)
- DSTN (40)
- EPN2 (40)
- FBXO21 (40)
- PRKAR2A (40)
- RAB21 (40)
- RHOJ (40)
- SCFD1 (40)
- SRR (40)
- STAT4 (40)
- TSC22D1 (40)
- TTLL12 (40)
- UNG (40)
- GLI1 (38)
- HADH (38)
- TNNT2 (38)
- HSPD1 (37)
- SNAP25 (37)
- ERG (36)
- POU2AF1 (36)
- SNX9 (36)
- APMAP (35)
- ARHGAP25 (35)
- BCL10 (35)
- CMPK1 (35)
- DNM1L (35)
- ESR1 (35)
- GADD45G (35)
- GPR17 (35)
- ID3 (35)
- LPL (35)
- MMP13 (35)
- NR3C1 (35)
- NRBP1 (35)
- PIK3R5 (35)
- PIM2 (35)
- PSMB9 (35)
- RFXANK (35)
- RGS16 (35)
- RPA2 (35)
- SERBP1 (35)
- SYP (35)
- TBC1D21 (35)
- TLK2 (35)
- TRMT2A (35)
- USP7 (35)
- NKX2-1 (34)
- FOS (33)
- PARN (33)
Antibody Hosts
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (8)
- Phospho-specific (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
Assay Types
Families
- Druggable Genome (10130)
- Transcription Factors (2752)
- Transmembrane (1922)
- Protein Kinase (1504)
- ES Cell Differentiation/IPS (1202)
- Stem cell - Pluripotency (918)
- Protease (817)
- Secreted Protein (666)
- Adult stem cells (215)
- Nuclear Hormone Receptor (211)
- Phosphatase (168)
- Cancer stem cells (139)
- Embryonic stem cells (137)
- Stem cell relevant signaling - JAK/STAT signaling pathway (110)
- Stem cell relevant signaling - DSL/Notch pathway (108)
- P450 (78)
- Induced pluripotent stem cells (67)
- GPCR (60)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (56)
- Ion Channels: Other (50)
- Ion Channels: Potassium (19)
- Stem cell relevant signaling - Wnt Signaling pathway (18)
- Ion Channels: Cys-loop Receptors (16)
- Ion Channels: Transient receptor potential (4)
- Ion Channels: Sodium (2)
- Ion Channels: Calcium (1)
- Ion Channels: Glutamate Receptors (1)
Pathways
- Metabolic pathways (2313)
- Pathways in cancer (1517)
- Focal adhesion (1070)
- MAPK signaling pathway (1009)
- Prostate cancer (871)
- ErbB signaling pathway (855)
- Colorectal cancer (846)
- Neurotrophin signaling pathway (768)
- Insulin signaling pathway (740)
- Endometrial cancer (726)
- Toll-like receptor signaling pathway (701)
- B cell receptor signaling pathway (692)
- Fc epsilon RI signaling pathway (682)
- Pancreatic cancer (677)
- Regulation of actin cytoskeleton (677)
- T cell receptor signaling pathway (672)
- Non-small cell lung cancer (647)
- Renal cell carcinoma (634)
- Acute myeloid leukemia (627)
- Glioma (609)
- Melanoma (599)
- Progesterone-mediated oocyte maturation (594)
- Chronic myeloid leukemia (583)
- Fc gamma R-mediated phagocytosis (524)
- Chemokine signaling pathway (523)
- GnRH signaling pathway (521)
- VEGF signaling pathway (509)
- Bladder cancer (500)
- Natural killer cell mediated cytotoxicity (454)
- Purine metabolism (399)
- Apoptosis (394)
- Small cell lung cancer (389)
- Gap junction (379)
- Wnt signaling pathway (376)
- Pyrimidine metabolism (375)
- Thyroid cancer (371)
- Melanogenesis (368)
- mTOR signaling pathway (363)
- Oocyte meiosis (361)
- Endocytosis (358)
- Adherens junction (356)
- Leukocyte transendothelial migration (346)
- Cell cycle (342)
- Type II diabetes mellitus (324)
- Alzheimer's disease (323)
- Prion diseases (323)
- Jak-STAT signaling pathway (314)
- Long-term potentiation (312)
- Glycolysis / Gluconeogenesis (305)
- Arginine and proline metabolism (300)
- Long-term depression (298)
- Vascular smooth muscle contraction (294)
- Amyotrophic lateral sclerosis (ALS) (276)
- Nucleotide excision repair (270)
- Ubiquitin mediated proteolysis (270)
- Valine (262)
- leucine and isoleucine degradation (262)
- Calcium signaling pathway (257)
- Dorso-ventral axis formation (255)
- Epithelial cell signaling in Helicobacter pylori infection (248)
- Phosphatidylinositol signaling system (239)
- Tight junction (234)
- Axon guidance (225)
- Parkinson's disease (217)
- Adipocytokine signaling pathway (216)
- Pathogenic Escherichia coli infection (209)
- Inositol phosphate metabolism (208)
- DNA replication (202)
- Fatty acid metabolism (199)
- Huntington's disease (196)
- Mismatch repair (188)
- Basal cell carcinoma (185)
- RNA degradation (183)
- Butanoate metabolism (182)
- TGF-beta signaling pathway (176)
- Propanoate metabolism (170)
- Base excision repair (169)
- Lysine degradation (169)
- Spliceosome (168)
- Alanine (166)
- Cell adhesion molecules (CAMs) (166)
- aspartate and glutamate metabolism (166)
- p53 signaling pathway (155)
- Hypertrophic cardiomyopathy (HCM) (154)
- Dilated cardiomyopathy (151)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (150)
- Pyruvate metabolism (141)
- Oxidative phosphorylation (139)
- Glycine (134)
- serine and threonine metabolism (134)
- Proteasome (133)
- Cytokine-cytokine receptor interaction (131)
- Primary immunodeficiency (130)
- Tryptophan metabolism (127)
- Tyrosine metabolism (125)
- One carbon pool by folate (124)
- ABC transporters (118)
- Hedgehog signaling pathway (117)
- beta-Alanine metabolism (114)
- Arachidonic acid metabolism (111)
- Pentose phosphate pathway (110)
- Glutathione metabolism (109)
- Cardiac muscle contraction (105)
- NOD-like receptor signaling pathway (104)
- Histidine metabolism (100)
- Notch signaling pathway (99)
- Glycerolipid metabolism (95)
- Drug metabolism - cytochrome P450 (94)
- Terpenoid backbone biosynthesis (93)
- Antigen processing and presentation (92)
- PPAR signaling pathway (91)
- Fatty acid elongation in mitochondria (88)
- Starch and sucrose metabolism (87)
- Lysosome (80)
- Amino sugar and nucleotide sugar metabolism (75)
- Citrate cycle (TCA cycle) (73)
- RIG-I-like receptor signaling pathway (73)
- Vibrio cholerae infection (72)
- Metabolism of xenobiotics by cytochrome P450 (70)
- Cysteine and methionine metabolism (69)
- Neuroactive ligand-receptor interaction (69)
- Retinol metabolism (67)
- Complement and coagulation cascades (65)
- Circadian rhythm - mammal (60)
- Fructose and mannose metabolism (60)
- Galactose metabolism (60)
- Nicotinate and nicotinamide metabolism (60)
- Synthesis and degradation of ketone bodies (60)
- Maturity onset diabetes of the young (59)
- Renin-angiotensin system (57)
- Type I diabetes mellitus (57)
- Folate biosynthesis (56)
- SNARE interactions in vesicular transport (55)
- Regulation of autophagy (52)
- N-Glycan biosynthesis (50)
- Hematopoietic cell lineage (48)
- Nitrogen metabolism (47)
- Methane metabolism (46)
- Selenoamino acid metabolism (45)
- Ribosome (44)
- Systemic lupus erythematosus (44)
- Porphyrin and chlorophyll metabolism (43)
- RNA polymerase (39)
- Viral myocarditis (39)
- Glyoxylate and dicarboxylate metabolism (38)
- ECM-receptor interaction (37)
- Homologous recombination (35)
- Cytosolic DNA-sensing pathway (34)
- Aminoacyl-tRNA biosynthesis (30)
- Phenylalanine metabolism (30)
- Sulfur metabolism (30)
- Other glycan degradation (28)
- Sphingolipid metabolism (28)
- Androgen and estrogen metabolism (25)
- Caffeine metabolism (25)
- Drug metabolism - other enzymes (25)
- Pantothenate and CoA biosynthesis (25)
- Ascorbate and aldarate metabolism (20)
- Fatty acid biosynthesis (20)
- Glycerophospholipid metabolism (20)
- Vitamin B6 metabolism (20)
- Primary bile acid biosynthesis (19)
- Cyanoamino acid metabolism (15)
- Glycosaminoglycan degradation (15)
- Taurine and hypotaurine metabolism (15)
- Olfactory transduction (11)
- D-Glutamine and D-glutamate metabolism (10)
- Ether lipid metabolism (10)
- Limonene and pinene degradation (10)
- Non-homologous end-joining (10)
- O-Glycan biosynthesis (10)
- Steroid biosynthesis (10)
- Taste transduction (10)
- Thiamine metabolism (10)
- Riboflavin metabolism (8)
- Allograft rejection (5)
- Autoimmune thyroid disease (5)
- Basal transcription factors (5)
- Biosynthesis of unsaturated fatty acids (5)
- Glycosphingolipid biosynthesis - lacto and neolacto series (5)
- Graft-versus-host disease (5)
- Keratan sulfate biosynthesis (5)
- Protein export (5)
- leucine and isoleucine biosynthesis (5)